Monoamine oxidase inhibition by a new carcinostatic agent, N-isopropyl-a92-methylhydrazino)-p-toluamide (MIH).
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects; D006168:Guinea Pigs; D006834:Hydrazines / Q000494:pharmacology*; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D013347:Subcellular Fractions / Q000378:metabolism; D014364:Tryptophan / Q000494:pharmacology
D000970:Antineoplastic Agents; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D014364:Tryptophan